Is Pay Transparency Good?
Journal of Economic Perspectives · 01.02.2024 · 38 (1) · 153-180
DOI: 10.1257/jep.38.1.153 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Economic Perspectives, erschienen am 01.02.2024. Verfasst von Zoë Cullen. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 139 Literaturangaben.
Abstract (Originalsprache)
Countries around the world are enacting pay transparency policies to combat pay discrimination. Since 2000, 71 percent of OECD countries have done so. Most are enacting transparency horizontally, revealing pay between coworkers doing similar work within a firm. While these policies have narrowed coworker wage gaps, they have also led to counterproductive peer comparisons and caused employers to bargain more aggressively, lowering average wages. Other pay transparency policies, without directly targeting discrimination, have benefited workers by addressing broader information frictions in the labor market. Vertical pay transparency policies reveal to workers pay differences across different levels of seniority. Empirical evidence suggests these policies can lead to more accurate and more optimistic beliefs about earnings potential, increasing employee motivation and productivity. Cross-firm pay transparency policies reveal wage differences across employers. These policies have encouraged workers to seek jobs at higher paying firms, negotiate higher pay, and sharpened wage competition between employers. We discuss the evidence on effects of pay transparency, and open questions.
Zitieren
APA
Cullen, Z. (2024). Is Pay Transparency Good?. Journal of Economic Perspectives, 38(1), 153-180. https://doi.org/10.1257/jep.38.1.153
Vancouver
Cullen Z. Is Pay Transparency Good?. Journal of Economic Perspectives. 2024;38(1):153-180. doi:10.1257/jep.38.1.153
BibTeX
@article{Cullen2024,
author = {Cullen, Zoë},
title = {Is Pay Transparency Good?},
journal = {Journal of Economic Perspectives},
year = {2024},
volume = {38},
number = {1},
pages = {153--180},
doi = {10.1257/jep.38.1.153}
}
EUVIMED